|
|
||||||||
The Annals of Thoracic Surgery, Vol 43, 617-621, Copyright © 1987 by The Society of Thoracic Surgeons
RG Makhoul, RL McCann, EH Austin, CS Greenberg and JE Lowe
Heparin-associated thrombocytopenia and thrombosis (HATT) is a serious
complication of heparin therapy that results in intravascular platelet
aggregation with arterial or venous thrombosis. Platelet aggregation to
heparin in vitro is used to confirm the diagnosis. Cessation of heparin
therapy with avoidance of reexposure to heparin is an important principle
in the management of HATT. However, certain patients with HATT may require
reexposure to heparin for emergency cardiac operations requiring
cardiopulmonary bypass while still demonstrating positive in vitro platelet
aggregation with heparin. The present report describes the management of 2
such patients. In each patient aspirin was shown to inhibit platelet
aggregation to heparin in vitro; therefore, aspirin and dipyridamole were
administered to each patient before heparin reexposure and continued
throughout the perioperative period. Cardiopulmonary bypass with full
heparinization was achieved without thrombotic or hemorrhagic complications
in both patients. Despite the presence of a heparin-dependent
platelet-aggregating factor in the plasma of these 2 patients, inhibition
of platelet aggregation with aspirin and dipyridamole allowed uneventful
reexposure to heparin.
ARTICLES
Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery
This article has been cited by other articles:
![]() |
N. Lubenow, R. Kempf, A. Eichner, P. Eichler, L. E. Carlsson, and A. Greinacher Heparin-Induced Thrombocytopenia* : Temporal Pattern of Thrombocytopenia in Relation to Initial Use or Reexposure to Heparin Chest, July 1, 2002; 122(1): 37 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Follis and C. A. Schmidt Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis Ann. Thorac. Surg., December 1, 2000; 70(6): 2173 - 2181. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P Reilly, R. Weiss, A. Askenase, C. Tuite, M. Soulen, and E. R Mohler III Hirudin therapy during thrombolysis for venous thrombosis in heparin-induced thrombocytopenia Vascular Medicine, November 1, 2000; 5(4): 239 - 242. [Abstract] [PDF] |
||||
![]() |
D. E. Wallis, B. E. Lewis, H. Messmore, and W. H. Wehrmacher State-of-the-Art Review : Heparin-induced Thrombocytopenia and Thrombosis Syndrome Clinical and Applied Thrombosis/Hemostasis, July 1, 1998; 4(3): 160 - 163. [PDF] |
||||
![]() |
D. Cummins and E. Hill Heparin-Induced Thrombocytopenia Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1997; 1(4): 349 - 365. [Abstract] [PDF] |
||||
![]() |
A. Kalangos, J. Y. M. Relland, A. Altes, R. Martino, M. Gari, M. L. Camara, R. Garin, J.-I. Casas, and J. Fontcuberta Therapeutic Implications for Heparin-Induced Thrombocytopenia and Thrombosis Ann. Thorac. Surg., October 1, 1995; 60(4): 1159 - 1160. [Full Text] |
||||
![]() |
S. Kleinschmidt and U.T. Seyfert Heparin-Associated Thrombocytopenia (HAT)--Still a Diagnostic and Therapeutical Problem in Clinical Practice Angiology, January 1, 1995; 46(1): 37 - 44. [Abstract] [PDF] |
||||
![]() |
M. Sobel Heparin-Induced Thrombocytopenia Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1992; 5(2): 1 - 27. [PDF] |
||||
![]() |
H. Van Damme, P. Damas, J.L. David, and R. Limet Heparin-Induced Thrombocytopenia: A Case Report Angiology, December 1, 1990; 41(12): 1075 - 1081. [Abstract] [PDF] |
||||
![]() |
D. J. Cohen, R. Briggs, H. D. Head, and C. W. Acher Phlegmasia Cerulea Dolens and Its Association with Hypercoagulable States: Case Reports Angiology, May 1, 1989; 40(5): 498 - 508. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |